Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001837607-25-000022
Filing Date
2025-03-24
Accepted
2025-03-24 16:07:40
Documents
97
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K aeon-20241231x10k.htm   iXBRL 10-K 3103782
2 EX-19 aeon-20241231xex19.htm EX-19 28858
3 EX-21 aeon-20241231xex21.htm EX-21 2610
4 EX-23 aeon-20241231xex23.htm EX-23 2864
5 EX-31 aeon-20241231xex31.htm EX-31 16112
6 EX-32 aeon-20241231xex32.htm EX-32 9094
7 GRAPHIC aeon-20241231xex19g001.jpg GRAPHIC 239838
8 GRAPHIC aeon-20241231xex19g002.jpg GRAPHIC 230335
9 GRAPHIC aeon-20241231xex19g003.jpg GRAPHIC 234996
10 GRAPHIC aeon-20241231xex19g004.jpg GRAPHIC 182980
11 GRAPHIC aeon-20241231xex19g005.jpg GRAPHIC 219945
12 GRAPHIC aeon-20241231xex19g006.jpg GRAPHIC 199076
13 GRAPHIC aeon-20241231xex19g007.jpg GRAPHIC 170573
14 GRAPHIC aeon-20241231xex19g008.jpg GRAPHIC 36819
15 GRAPHIC aeon-20241231xex19g009.jpg GRAPHIC 41471
  Complete submission text file 0001837607-25-000022.txt   15565201

Data Files

Seq Description Document Type Size
16 EX-101.SCH aeon-20241231.xsd EX-101.SCH 108115
17 EX-101.CAL aeon-20241231_cal.xml EX-101.CAL 67459
18 EX-101.DEF aeon-20241231_def.xml EX-101.DEF 474507
19 EX-101.LAB aeon-20241231_lab.xml EX-101.LAB 810575
20 EX-101.PRE aeon-20241231_pre.xml EX-101.PRE 664861
100 EXTRACTED XBRL INSTANCE DOCUMENT aeon-20241231x10k_htm.xml XML 2381745
Mailing Address 5 PARK PLAZA SUITE 1750 IRVINE CA 92614
Business Address 5 PARK PLAZA SUITE 1750 IRVINE CA 92614 (949) 354-6499
AEON Biopharma, Inc. (Filer) CIK: 0001837607 (see all company filings)

EIN.: 853940478 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-40021 | Film No.: 25764232
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)